Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMWZOD7)

Drug Name
CNVN-202 Drug Info
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMWZOD7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Tumor suppressor candidate 2 (TUSC2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fus-1 tumor suppressor gene therapy DMXV6YP Non-small-cell lung cancer 2C25.Y Phase 1/2 [3]
Quaratusugene ozeplasmid DMZD7OA Non-small-cell lung cancer 2C25.Y Phase 1/2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tumor suppressor candidate 2 (TUSC2) TTJ8O14 TUSC2_HUMAN Suppressor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018766)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018766)
3 INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201. Drugs R D. 2007;8(3):176-87.
4 Clinical pipeline report, company report or official report of Genprex.